Colorectal Cancer Clinical Trials in Miami

Showing 41-60 of 126 trials

Precise Oncology Interventions in Nutrition and Training (OnPoint)

NCT06534918

The purpose of this study is to see if survivors of breast, prostate, or colorectal cancer who receive a personal referral to a targeted nutrition and exercise program will be able to eat a healthier diet and be more physically activity.

Breast CancerProstate CancerColorectal Cancer

University of Miami306 participantsStarted Sep 2024

Miami, Florida, United States

TERMINATEDPhase 1< 1 mile

A Study of LY3039478 in Participants With Advanced or Metastatic Solid Tumors

NCT02784795

The main purpose of this study is to evaluate the safety of the study drug known as LY3039478 in combination with other anticancer agents in participants with advanced or metastatic solid tumors.

Solid TumorBreast CancerColon Cancer+2 more

Eli Lilly and Company94 participantsStarted Nov 2016

Miami, Florida, United States • Detroit, Michigan, United States • New York, New York, United States +8 more locations

Precise Oncology Interventions in Nutrition and Training (OnPoint)

A Study of LY3039478 in Participants With Advanced or Metastatic Solid Tumors

Colorectal Cancer Trials in Other Cities

DNA Evaluation of Fragments for Early Interception - Lung Cancer Training Study (DELFI-L101 Study)

89Zr-girentuximab for PET Imaging of CAIX Positive Solid Tumors

Phase 2 Trial of Voyager V1 in Combination With Cemiplimab in Cancer Patients

ME-344 and Bevacizumab in Previously Treated Metastatic Colorectal Cancer

Evaluation of the ctDNA LUNAR Test in an Average Patient Screening Episode

Safety, PK and Efficacy of ONC-392 in Monotherapy and in Combination of Anti-PD-1 in Advanced Solid Tumors and NSCLC

Circulating Tumor DNA Testing in Predicting Treatment for Patients With Stage IIA Colon Cancer After Surgery

Study of Onvansertib in Combination With FOLFIRI and Bevacizumab Versus FOLFIRI and Bevacizumab for Second Line Treatment of Metastatic Colorectal Cancer in Participants With a Kirsten Rat Sarcoma Virus Gene (KRAS) or Neuroblastoma-RAS (NRAS) Mutation

A Dose Escalation Study of SHP2 Inhibitor in Patients With Solid Tumors Harboring KRAS of EGFR Mutations

A Study Assessing Adverse Events and Disease Activity When Comparing Intravenously (IV) Infused ABBV-400 to Trifluridine and Tipiracil (LONSURF) Oral Tablets Plus IV Infused Bevacizumab in Adult Participants With c-Met Protein Above Cutoff Level Above Refractory Metastatic Colorectal Cancer

Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors

Study of Seribantumab in Adult Patients With NRG1 Gene Fusion Positive Advanced Solid Tumors

A Study Investigating the Efficacy and Safety of LBL-007 Plus Tislelizumab in Combination With Bevacizumab Plus Fluoropyrimidine Versus Bevacizumab Plus Fluoropyrimidine in Participants With Unresectable or Metastatic Colorectal Cancer

Tovorafenib (DAY101) Monotherapy for Patients With Melanoma and Other Solid Tumors

Oral AMXT 1501 Dicaprate in Combination With IV DFMO

A Study of [225Ac]-FPI-2059 in Adult Participants With Solid Tumours

Health Education Materials With/Out a Physical Activity Program for Patients Who Have Undergone Treatment for High-Risk Stage II or Stage III Colon Cancer

A Study to Investigate BGB-3245 (Brimarafenib) With Panitumumab in Participants With Advanced or Metastatic RAS Mutant Colorectal and Pancreatic Ductal Cancers

Other Conditions in Miami